| 1 | [SID24813372] | Active | IC50 | 2.278 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) [AID504317, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | IC50 | 2.278 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) | | AID | 504317 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 2 | [SID24813372] | Active | IC50 | 3.103 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) [AID504319, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | IC50 | 3.103 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) | | AID | 504319 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 3 | [SID24813372] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID24813372] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 5 | [SID24813372] | Active | Potency | 6.3096 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 6 | [SID24813372] | Active | Potency | 6.3096 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 7 | [SID24813372] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID24813372] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID24813372] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID24813372] | Active | EC50 | 8.29 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | EC50 | 8.29 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 11 | [SID24813372] | Active | EC50 | 8.29 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | EC50 | 8.29 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 12 | [SID24813372] | Active | Potency | 9.4662 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 9.4662 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 13 | [SID24813372] | Active | Potency | 10.691 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 10.691 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 14 | [SID24813372] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID24813372] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID24813372] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID24813372] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 18 | [SID24813372] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 19 | [SID24813372] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 20 | [SID24813372] | Active | Potency | 22.3872 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 21 | [SID24813372] | Active | Potency | 25.7247 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 25.7247 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 22 | [SID24813372] | Active | Potency | 25.7247 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 25.7247 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 23 | [SID24813372] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 24 | [SID24813372] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 25 | [SID24813372] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID24813372] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID24813372] | Active | | | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules. [AID1381, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules. | | AID | 1381 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID24813372] | Active | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID24813372] | Active | | | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules: Confirmation Assay [AID463116, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules: Confirmation Assay | | AID | 463116 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID24813372] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 31 | [SID24813372] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 32 | [SID24813372] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 33 | [SID24813372] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 34 | [SID24813372] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 35 | [SID24813372] | Active | | | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504550, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Single concentration confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504550 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 36 | [SID24813372] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 37 | [SID24813372] | Active | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 38 | [SID24813372] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 39 | [SID24813372] | Active | | | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen [AID1422, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen | | AID | 1422 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 40 | [SID24813372] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 41 | [SID24813372] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 42 | [SID24813372] | Active | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) [AID493027, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) | | AID | 493027 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 43 | [SID24813372] | Active | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID493035, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 493035 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 44 | [SID24813372] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 45 | [SID24813372] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 46 | [SID24813372] | Active | | | Confirmatory screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID2032, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 2032 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 47 | [SID24813372] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 48 | [SID24813372] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 49 | [SID24813372] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID24813372] | Inactive | Potency | 25.1189 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24813372 | | CID | 5337766 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|